STATE STREET CORP - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 84 filers reported holding SEELOS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$72,387
-80.7%
393,405
+25.1%
0.00%
Q2 2023$375,714
+72.9%
314,4050.0%0.00%
Q1 2023$217,317
-49.1%
314,405
-50.0%
0.00%
Q4 2022$426,962
+31.8%
628,810
+100.0%
0.00%
Q3 2022$324,000
+51.4%
314,4050.0%0.00%
Q2 2022$214,000
-85.4%
314,405
-82.0%
0.00%
Q1 2022$1,462,000
-46.0%
1,745,269
+5.1%
0.00%
Q4 2021$2,706,000
-28.9%
1,660,304
+5.1%
0.00%
Q3 2021$3,807,000
+22.5%
1,579,863
+34.1%
0.00%
Q2 2021$3,109,0001,177,7660.00%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 2,500,000$4,075,0001.71%
Connacht Asset Management LP 498,925$813,0000.79%
GENDELL JEFFREY L 2,449,267$3,992,0000.32%
MANGROVE PARTNERS IM, LLC 2,133,436$3,478,0000.21%
Uniplan Investment Counsel, Inc. 1,550,359$2,527,0000.14%
Financial Advocates Investment Management 24,673$1,994,0000.13%
Connacht Asset Management LP 72,300$118,0000.12%
Woodline Partners LP 4,047,231$6,597,0000.09%
1492 Capital Management LLC 108,286$177,0000.09%
Ikarian Capital, LLC 244,171$398,0000.06%
View complete list of SEELOS THERAPEUTICS INC shareholders